Linike Medical Group

Linike Medical Group Rule of 40

The Rule of 40 of Linike Medical Group (LNMG) as of Oct 31, 2026 is 10.73 %. In the previous year, Rule of 40 was 43.86 % — a change of -75.54% (lower).

Rule of 40

10.73 %

YoY

-75.54%

Last updated:

Rule of 40 of Linike Medical Group is 2025 10.73 % . Rule of 40 of Linike Medical Group was 2024 43.86 % . It decreases by -75.54% lower compared to the previous year.

The Linike Medical Group Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2024
43.86 USD
Jan 1, 2025
10.73 USD
The Linike Medical Group Rule of 40 history
YEARRule of 40YoY
10.73 %-75.54%
43.86 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linike Medical Group Stock analysis

What does Linike Medical Group do? Linike Medical Group Ltd, headquartered in Las Vegas, Nevada, operates in the energy sector, focusing on oil and natural gas exploration. The company, listed on 17 May 2012, has subsidiaries including China Linike Medical Group Ltd and Sichuan Huarong Zhengtai Medical Technology Co., Ltd. Its primary business involves the exploration and development of energy resources. Linike Medical Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linike Medical Group stock

Rule of 40 of Linike Medical Group is 10.73 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Linike Medical Group since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Linike Medical Group

All Key Metrics — Linike Medical Group